The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

The Safety of Artemisinin Derivatives for the Treatment of Malaria in the 2nd or 3rd Trimester of Pregnancy: A Systematic Review and Meta-Analysis

Published:2016-11-08 Issue:11 Volume:11 Page:e0164963
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kovacs Stephanie D.^ORCID,van Eijk Anna Maria,Sevene Esperanca,Dellicour Stephanie,Weiss Noel S.,Emerson Scott,Steketee Richard,ter Kuile Feiko O.,Stergachis Andy

Funder

National Institutes of Health

Bill and Melinda Gates Foundation

PATH

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference45 articles.

1. Epidemiology and burden of malaria in pregnancy;M Desai;Lancet Infect Dis,2007

2. Antimalarial drugs in pregnancy: a review;F Nosten;Curr Drug Saf,2006

3. New medicines for tropical diseases in pregnancy: catch-22;NJ White;PLoS Med,2008

4. World malaria report 2014,2014

5. WHO Malaria Policy Advisory Committee and Secretariate Malaria Policy Advisory Committee to the WHO conclusions and recommendations of September 2012 meeting. Malar J. 20`4; 11: 424. 10.1186/1475-2875-11-424.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Have You Heard the News? Artemether-lumefantrine is Now Recommended for ALL Uncomplicated Malaria in the United States, Including in Pregnancy;Clinical Infectious Diseases;2023-10-17

2. Malaria in pregnancy: adverse pregnancy outcomes and the future of prevention;Frontiers in Tropical Diseases;2023-08-14

3. First-trimester use of ACTs for malaria treatment in pregnancy;The Lancet;2023-01

4. The cytotoxic activity of artemisinin, doxorubicin and mixture on cell line (cancer colorectal, L20B and normal cells);4TH INTERNATIONAL SCIENTIFIC CONFERENCE OF ALKAFEEL UNIVERSITY (ISCKU 2022);2023

5. Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial;Clinical Infectious Diseases;2022-10-11